Ms Caroline Garvan:

It is good value for money. It will allow us to comply with our European requirements and have the information. It will allow us to access other markets abroad because we will show full oversight of the antibiotics, in particular, that are used in our animals. It will also allow us to protect human and animal health. It is good value for money.